Avidity Biosciences Joins with Patients, Caregivers and Healthcare Providers Globally to Support World Facioscapulohumeral Muscular Dystrophy (FSHD) Day

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

Related Keywords

Italy ,United States ,Milan ,Lombardia ,San Diego ,California ,Sarah Boyce ,Kathleen Gallagher ,Mark Stone ,Navjot Rai ,Exchange Commission ,Avidity Biosciences Inc ,Prnewswire Avidity Biosciences Inc ,Linkedin ,Alliance Leadership Summit ,Nasdaq ,Global Task Force Of Project Mercury ,European Medicines Agency ,Drug Administration ,Society International Research Congress ,Twitter ,Health Economics ,Antibody Oligonucleotide Conjugates ,World Facioscapulohumeral Muscular Dystrophy ,International Research Congress ,Economics Outreach ,Global Task Force ,Project Mercury ,Facioscapulohumeral Muscular Dystrophy ,Oligonucleotide Conjugates ,Annual Report ,Private Securities Litigation Reform Act ,Avidity Biosciences ,Nc ,